This Working Group aimed to enhance participation in clinical trials that are reflective of the population by focusing on developing innovations in community engagement, operational efficiency, regulatory compliance, informatics, and workforce development.
Harnessing Innovation and Engagement in Clinical Trials
Overview
This Working Group aimed to enhance participation in clinical trials that are reflective of the population by focusing on developing innovations in community engagement, operational efficiency, regulatory compliance, informatics, and workforce development.
Group Goals
Act as an organizing and convening body on behalf of the CTSA consortium to invite stakeholders external to the CTSA hubs but critical to the work such as FDA, industry partners, patient groups, and community leaders.
To identify best practices and models of success, which have the potential to be disseminated and adopted broadly across CTSA hubs.
To codify lessons-learned related to challenges and solutions encountered by CTSA hubs to overcome barriers related to enrollment and retention reflective of the population.
To define clear evaluation criteria which hubs can use to measure progress and that NCATS can use to demonstrate impact both to the general public and in justification of the value of the CTSA program.
Meeting Archive
This group met regularly to work towards achieving the goals of the CTSA Program. For questions, please contact support@ccos.ctsa.io.
